KalVista Pharmaceuticals | 8-K:重大事件
04/22 16:58 (美东)
KalVista Pharmaceuticals | 4:持股变动声明-董事 Fairey William
04/22 16:42 (美东)
KalVista Pharmaceuticals | 3:首次持股声明-董事 Fairey William
04/22 16:38 (美东)
KalVista Pharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-TCG Crossover GP I, LLC(3.2%),TCG Crossover Fund I, L.P.(3.2%)等
04/01 16:19 (美东)
KalVista Pharmaceuticals | 8-K:KalVista 制药公司公布第三财季业绩并提供最新运营情况
03/11 16:45 (美东)
KalVista Pharmaceuticals | 10-Q:季度报表
03/11 16:28 (美东)
KalVista Pharmaceuticals | 4:持股变动声明-高管 Palleiko Benjamin L
03/08 16:52 (美东)
KalVista Pharmaceuticals | 8-K:重大事件
03/07 06:39 (美东)
KalVista Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Adage Capital Partners, L.P.(6.87%),Adage Capital Partners GP, L.L.C.(6.87%)等
02/26 16:44 (美东)
KalVista Pharmaceuticals | 4:持股变动声明-股东 Venrock Healthcare Capital Partners III, L.P.
02/22 16:17 (美东)
KalVista Pharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-James N. Topper(8.9%),Patrick J. Heron(8.9%)等
02/22 13:27 (美东)
KalVista Pharmaceuticals | 4:持股变动声明-高管 Feener Edward P.
02/21 21:52 (美东)
KalVista Pharmaceuticals | 4:持股变动声明-高管 Yea Christopher
02/21 21:52 (美东)
KalVista Pharmaceuticals | 4:持股变动声明-高管 Palleiko Benjamin L
02/21 21:52 (美东)
KalVista Pharmaceuticals | 4:持股变动声明-高管 Audhya Paul K.
02/21 21:47 (美东)
KalVista Pharmaceuticals | 4:持股变动声明-高管 Crockett Thomas Andrew
02/21 21:47 (美东)
KalVista Pharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-TCG Crossover GP I, LLC(6.52%),TCG Crossover Fund I, L.P.(6.52%)等
02/20 16:54 (美东)
KalVista Pharmaceuticals | 8-K:重大事件
02/16 16:40 (美东)
KalVista Pharmaceuticals | 424B5:募资说明书
02/16 16:32 (美东)
KalVista Pharmaceuticals | 4:持股变动声明-高管 Yea Christopher
02/16 16:25 (美东)
暂无数据
暂无数据